FDA expands indication for On-X Life's heart valve
On-X Life Technologies wins an expanded labeling indication from the FDA for its replacement heart valve.
On-X Life Technologies said it nailed down an expanded labeling claim from the FDA for its aortic mechanical heart valve.
Food & Drug Administration (FDA), On-X Life TechnologiesNews Well, Regulatory/Compliance, Replacement Heart Valvesread more
Source: Mass Device - Category: Medical Equipment Authors: Mark Hollmer Source Type: news
More News: Cardiology | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Medical Devices